ClinConnect ClinConnect Logo
Search / Trial NCT05247112

Prevalence and Trends of Antimicrobial Resistance of Helicobacter Pylori in Korea

Launched by SEOUL NATIONAL UNIVERSITY BUNDANG HOSPITAL · Feb 8, 2022

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

Eradication Rescue Therapy Antibiotics Resistance Helicobacter Pylori

ClinConnect Summary

This clinical trial is studying the rates of antibiotic resistance in a bacteria called Helicobacter pylori (H. pylori), which can cause stomach problems. Researchers want to understand how resistant this bacteria is to different antibiotics over time. They are specifically looking at patients with upper gastrointestinal diseases who have been diagnosed with an H. pylori infection and will be undergoing a procedure called endoscopy to collect samples for testing.

To participate in this study, patients need to have an H. pylori infection and be willing to allow their samples to be analyzed to see how well different antibiotics can work against the bacteria. However, individuals who have serious health issues, misuse drugs or alcohol, are pregnant or nursing, or have taken certain medications recently will not be eligible. Participants can expect to undergo an endoscopy, which is a safe procedure, and their results will help improve treatment options for H. pylori infections in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subjects who had a H. pylori infection and had consented to undergo culture analysis via endoscopic resection, in order to determine the minimal inhibitory concentration (MIC) of various antibiotics.
  • Exclusion Criteria:
  • Patients with a concurrent critical illness, who abused drugs or alcohol, who were pregnant or nursing, or those who had received antibiotics, PPIs, or bismuth salts within 4 weeks, were excluded.

About Seoul National University Bundang Hospital

Seoul National University Bundang Hospital is a leading academic medical center located in South Korea, renowned for its commitment to innovative research and excellence in patient care. As a sponsor of clinical trials, the hospital leverages its extensive expertise in various medical fields, employing cutting-edge technologies and methodologies to advance healthcare solutions. With a multidisciplinary team of skilled researchers and clinicians, the hospital aims to enhance clinical outcomes through rigorous investigation and collaboration, contributing significantly to the global medical community and improving patient lives.

Locations

Seongnam Si, Gyeonggi Do, Korea, Republic Of

Patients applied

0 patients applied

Trial Officials

Nayoung Kim, M.D., Ph.D

Study Chair

Seoul National University Bundang Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials